Fortis Healthcare Adjusts Valuation Grade Amid Mixed Performance in Healthcare Sector

Fortis Healthcare has recently undergone a valuation adjustment, reflecting its current standing in the Hospital & Healthcare Services industry. The company's price-to-earnings (PE) ratio stands at 57.19, while its price-to-book value is noted at 5.75. Other key metrics include an EV to EBIT ratio of 39.48 and an EV to EBITDA ratio of 29.81, indicating the company's operational performance relative to its valuation.
In terms of returns, Fortis Healthcare has shown a mixed performance against the Sensex. Over the past year, the stock has returned 36.32%, significantly outperforming the index, which recorded a return of 2.06%. However, year-to-date, Fortis has seen a decline of 16.96%, contrasting with the Sensex's 4.47% drop.

When compared to its peers, Fortis Healthcare's valuation metrics present a varied landscape. For instance, Max Healthcare is positioned at a higher valuation level, while Apollo Hospitals shares a similar valuation status. This context highlights Fortis's competitive positioning within the sector, emphasizing the importance of ongoing performance evaluation against its industry counterparts.